Soleus Capital Management, L.P.
An institutional investment manager in GREENWICH, CT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 11, 2026. SEC CIK 1802630.
- Reported value$2.90bn
- Positions97
Holdings: 97 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Krystal Biotech IncKRYS | COM | 501147102 | 349 | 12.0% | 939,254 | Reduced−213,833 | |
| Celcuity IncCELC | COM | 15102K100 | 178 | 6.1% | 1,704,318 | Added+419,940 | |
| TG Therapeutics IncTGTX | COM | 88322Q108 | 161 | 5.5% | 2,927,895 | Reduced−1,101,424 | |
| Insulet CorpPODD | COM | 45784P101 | 160 | 5.5% | 1,049,000 | Added+486,500 | |
| Novocure Ltd | ORD SHS | G6674U108 | 150 | 5.2% | 9,913,401 | Reduced−578,990 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 122 | 4.2% | 225,587 | Added+38,400 | |
| Inspire Med Sys IncINSP | COM | 457730109 | 86.2 | 3.0% | 1,931,436 | Added+1,355,137 | |
| Rigel Pharmaceuticals IncRIGL | COM | 766559702 | 72.1 | 2.5% | 1,843,504 | Added+1,833,504 | |
| ANI Pharmaceuticals IncANIP | COM | 00182C103 | 71.8 | 2.5% | 867,760 | Added+47,517 | |
| Beta Bionics IncBBNX | COM | 08659B102 | 68.8 | 2.4% | 4,393,714 | Added+39,213 | |
| Vericel CorpVCEL | COM | 92346J108 | 64.9 | 2.2% | 1,459,152 | Reduced−1,089,927 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 59.4 | 2.0% | 177,517 | Reduced−153,000 | |
| Geron CorpGERN | COM | 374163103 | 54.8 | 1.9% | 42,808,659 | Added+1,300,000 | |
| Alkermes plc | SHS | G01767105 | 53.9 | 1.9% | 1,029,252 | Reduced−941,612 | |
| Erasca IncERAS | COM | 29479A108 | 49.5 | 1.7% | 2,700,000 | New+2,700,000 | |
| Neuropace IncNPCE | COM | 641288105 | 46.3 | 1.6% | 2,911,122 | Reduced−21,085 | |
| Progyny IncPGNY | COM | 74340E103 | 46.2 | 1.6% | 1,602,000 | Reduced−465,000 | |
| Indivior Pharmaceuticals IncINDV | COM | 45579U109 | 43.7 | 1.5% | 1,064,000 | Reduced−210,000 | |
| Parabilis Medicines IncPBLS | COM | 698955101 | 40.1 | 1.4% | 1,465,070 | New+1,465,070 | |
| Edap TMS S aFOCL | SPONSORED ADR | 268311107 | 37.9 | 1.3% | 7,309,254 | Unchanged | |
| Globus Med IncGMED | CL A | 379577208 | 37.0 | 1.3% | 468,922 | Reduced−260,545 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 36.0 | 1.2% | 1,168,738 | Added+716,755 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 35.6 | 1.2% | 1,628,039 | Reduced−98,869 | |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 35.5 | 1.2% | 1,465,163 | Added+527,000 | |
| Legend Biotech CorpLEGN | SPONSORED ADS | 52490G102 | 34.8 | 1.2% | 1,205,000 | New+1,205,000 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 34.5 | 1.2% | 1,550,690 | Added+753,946 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 33.3 | 1.1% | 80,000 | New+80,000 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 30.6 | 1.1% | 1,654,978 | Added+1,213,000 | |
| Urogen Pharma Ltd | COM | M96088105 | 30.5 | 1.1% | 829,810 | Added+102,810 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 28.4 | 1.0% | 515,279 | Added+336,382 | |
| Palisade Bio IncPALI | COM | 696389402 | 27.3 | 0.9% | 13,063,687 | New+13,063,687 | |
| Pharvaris N V | COM | N69605108 | 25.3 | 0.9% | 730,907 | Added+28,855 | |
| Organogenesis Holdings IncORGO | COM | 68621F102 | 24.6 | 0.8% | 10,140,951 | Added+55,000 | |
| Supernus PharmaceuticalsSUPN | COM | 868459108 | 24.2 | 0.8% | 520,000 | New+520,000 | |
| Procept Biorobotics CorpPRCT | COM | 74276L105 | 22.6 | 0.8% | 1,003,000 | Added+843,000 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 22.2 | 0.8% | 709,000 | Added+259,000 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 22.1 | 0.8% | 10,875,000 | Unchanged | |
| Trevi Therapeutics IncTRVI | COM | 89532M101 | 22.0 | 0.8% | 1,179,618 | Reduced−440,382 | |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 21.5 | 0.7% | 375,572 | Reduced−275,000 | |
| Livanova plc | SHS | G5509L101 | 21.0 | 0.7% | 254,957 | Reduced−327,543 | |
| Argenx SEARGX | SPONSORED ADR | 04016X101 | 18.5 | 0.6% | 19,955 | Added+16,455 | |
| Nuvectis Pharma IncNVCT | COM | 67080T108 | 18.4 | 0.6% | 1,000,000 | New+1,000,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 18.3 | 0.6% | 761,737 | New+761,737 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 18.3 | 0.6% | 450,889 | Reduced−999,026 | |
| Prelude Therapeutics IncPRLD | COM | 74065P101 | 18.0 | 0.6% | 3,378,378 | New+3,378,378 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 16.1 | 0.6% | 267,000 | Reduced−25,000 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 15.8 | 0.5% | 3,377,981 | Reduced−425,961 | |
| Kiniksa Pharmaceuticals International | ORD SHS CL A | G52694109 | 15.8 | 0.5% | 246,353 | Reduced−275,000 | |
| Orthopediatrics CorpKIDS | COM | 68752L100 | 14.0 | 0.5% | 732,144 | Added+116,697 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 13.8 | 0.5% | 419,000 | New+419,000 | |
| Biodesix IncBDSX | COM | 09075X207 | 13.2 | 0.5% | 585,958 | Added+169,359 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 13.1 | 0.4% | 147,000 | New+147,000 | |
| Twist Bioscience CorpTWST | COM | 90184D100 | 10.8 | 0.4% | 104,629 | Reduced−1,122,000 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 10.2 | 0.4% | 1,000,000 | Reduced−1,002,000 | |
| Alnylam Pharmaceuticals IncALNY | COM | 02043Q107 | 9.9 | 0.3% | 33,050 | Reduced−98,600 | |
| Immunovant IncIMVT | COM | 45258J102 | 9.7 | 0.3% | 252,000 | Added+22,000 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 9.6 | 0.3% | 90,250 | Added+80,000 | |
| Septerna IncSEPN | COM | 81734D104 | 9.2 | 0.3% | 275,000 | Unchanged | |
| Sophia Genetics SA | ORDINARY SHARES | H82027105 | 9.0 | 0.3% | 1,565,000 | Reduced−285,000 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 9.0 | 0.3% | 128,362 | New+128,362 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 8.8 | 0.3% | 75,000 | Reduced−325,306 | |
| Artivion IncAORT | COM | 228903100 | 8.7 | 0.3% | 388,000 | New+388,000 | |
| Tandem Diabetes Care IncTNDM | COM NEW | 875372203 | 8.7 | 0.3% | 575,000 | Reduced−208,000 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 8.4 | 0.3% | 165,677 | Reduced−65,192 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 7.8 | 0.3% | 177,687 | Reduced−115,813 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 7.8 | 0.3% | 50,524 | New+50,524 | |
| Cerus CorpCERS | COM | 157085101 | 7.3 | 0.3% | 2,500,000 | Reduced−8,253,700 | |
| Silence Therapeutics plcSLN | ADS | 82686Q101 | 6.9 | 0.2% | 630,000 | New+630,000 | |
| Immunic IncIMUX | COM NEW | 4525EP200 | 6.9 | 0.2% | 450,000 | New+450,000 | |
| Invivyd IncIVVD | COM | 00534A102 | 6.7 | 0.2% | 7,708,727 | Unchanged | |
| Merck & Co IncMRK | COM | 58933Y105 | 6.4 | 0.2% | 50,000 | Reduced−153,000 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 5.8 | 0.2% | 842,106 | Unchanged | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 5.7 | 0.2% | 107,000 | Added+27,000 | |
| Evolus IncEOLS | COM | 30052C107 | 5.7 | 0.2% | 822,428 | Reduced−1,422,932 | |
| Adlai Nortye LtdANL | SPONSORED ADS | 00704R109 | 4.7 | 0.2% | 405,523 | New+405,523 | |
| Zentalis Pharmaceuticals IncZNTL | COM | 98943L107 | 4.6 | 0.2% | 950,000 | New+950,000 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 4.3 | 0.1% | 440,000 | Unchanged | |
| Context Therapeutics IncCNTX | COM | 21077P108 | 3.9 | 0.1% | 7,063,141 | Added+100,000 | |
| Pulmonx CorpLUNG | COM | 745848101 | 3.6 | 0.1% | 2,788,323 | Unchanged | |
| SAB Biotherapeutics IncSABS | COM NEW | 78397T202 | 3.5 | 0.1% | 900,000 | Reduced−150,000 | |
| Tectonic Therapeutic IncTECX | COM | 878972108 | 3.5 | 0.1% | 101,684 | Reduced−20,000 | |
| Axogen IncAXGN | COM | 05463X106 | 2.6 | <0.1% | 57,036 | Reduced−622,134 | |
| Satellos Bioscience IncMSLE | COM | 80401L803 | 2.4 | <0.1% | 314,359 | Reduced−100,000 | |
| Arrivent Biopharma IncAVBP | COM | 04272N102 | 1.7 | <0.1% | 50,000 | New+50,000 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 1.7 | <0.1% | 19,653 | Reduced−265,878 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 1.5 | <0.1% | 150,000 | New+150,000 | |
| Veracyte IncVCYT | COM | 92337F107 | 1.5 | <0.1% | 25,000 | Reduced−294,912 | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 0.9 | <0.1% | 50,000 | Reduced−360,200 | |
| Inspiremd IncNSPR | COM | 45779A846 | 0.7 | <0.1% | 1,045,708 | Unchanged | |
| Genedx Holdings CorpWGS | COM CL A | 81663L200 | 0.7 | <0.1% | 10,000 | New+10,000 | |
| Iovance Biotherapeutics IncIOVA | COM | 462260100 | 0.6 | <0.1% | 150,000 | Reduced−850,000 | |
| Larimar Therapeutics IncLRMR | COM | 517125100 | 0.6 | <0.1% | 188,102 | Reduced−878,858 | |
| CG Oncology IncCGON | COM | 156944100 | 0.4 | <0.1% | 5,000 | Reduced−15,000 | |
| Quoin Pharmaceuticals LtdQNRX | SPONSORED ADS | 74907L409 | 0.4 | <0.1% | 72,730 | Unchanged | |
| Equillium IncEQ | COM | 29446K106 | 0.3 | <0.1% | 90,000 | New+90,000 | |
| Natera IncNTRA | COM | 632307104 | 0.3 | <0.1% | 1,000 | Reduced−118,000 | |
| Neogenomics IncNEO | COM NEW | 64049M209 | 0.1 | <0.1% | 10,000 | Reduced−165,000 |
Sold out: 18 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Anaptysbio IncANAB | COM | 032724106 | 0.0 | 0.0% | 0 | Sold out−6,000 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 0.0 | 0.0% | 0 | Sold out−28,479 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 0.0 | 0.0% | 0 | Sold out−300,000 | |
| Dexcom IncDXCM | COM | 252131107 | 0.0 | 0.0% | 0 | Sold out−140,000 | |
| Eton Pharmaceuticals IncETON | COM | 29772L108 | 0.0 | 0.0% | 0 | Sold out−166,381 | |
| Icon plc | SHS | G4705A100 | 0.0 | 0.0% | 0 | Sold out−192,000 | |
| Immunic Inc | COM | 4525EP101 | 0.0 | 0.0% | 0 | Sold out−4,500,000 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 0.0 | 0.0% | 0 | Sold out−131,000 | |
| Jasper Therapeutics IncJSPR | COM NEW | 471871202 | 0.0 | 0.0% | 0 | Sold out−276,312 | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 0.0 | 0.0% | 0 | Sold out−5,000 | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Staar Surgical CoSTAA | COM PAR $0.01 | 852312305 | 0.0 | 0.0% | 0 | Sold out−20,000 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 0.0 | 0.0% | 0 | Sold out−546,000 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 0.0 | 0.0% | 0 | Sold out−385,472 | |
| Zymeworks IncZYME | COM | 98985Y108 | 0.0 | 0.0% | 0 | Sold out−10,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001802630-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.